World Market for Molecular Diagnostics
Potential and Reality, What's Hot and What's Not, The
| Product Code | KAL00003 |
| Publication Date | March 2011 |
| Publisher | Kalorama Information |
| Product Type | Report |
| Pages | 550 |
| ISBN Number | not applicable |
World Market for Molecular Diagnostics
Potential and Reality, What's Hot and What's Not, The
There are many sanguine predictions made about the molecular diagnostics but to be useful, context is needed. How can companies sort out what is effective and what is not in this market? For over a decade, Kalorama Information's lead diagnostics analyst Shara Rosen, R.T., MBA has reviewed the molecular diagnostics market. A lot has changed, and a lot has stayed the same. There is intense competition but also opportunities for entrants in some areas. This report The World Market for Molecular Diagnostics: Potential and Reality, What's Hot and What's Not provides current market data for business planning but also goes beyond the numbers to fully assess what is going on in the market. What are the important developments in the market? Who are the small innovators in this industry and how are the big players reacting to them? Which developments are "hot" - response from providers and payors and which trends have not caught on? In this report, Rosen provides answers to these questions. The Rewards, Pitfalls and Competition of This High Potential Market
As we enter the second decade of the 21st century the investment in molecular biology, in bioinformatics, in disease management research and the unraveling of the human genome is bearing fruit. Almost every day the discovery of new molecular markers for cancer, cardiac disease, diabetes, arthritis, neurological diseases and psychiatric conditions are announced. This title, The World Market for Molecular Diagnostics -Potential and Reality, What's Hot and What's Not provides a detailed examination of molecular testing today. Among the data points the report provides are the following:
Current Market Size and Forecast for Molecular Segments (Infectious Disease, Blood Screening, Histology, Oncology, Prenatal, Coagulation, Tissue Typing, Inherited Diseases, Pharmacodiagnostics and Other)
Infectious Disease Molecular Sales by Disease (Hepatitis, HIV, GC/Chlamydia, HAI, Respiratory, Organism ID, Mycobacteria/TB, others)
- Revenues of Top Molecular Diagnostic Companies
- Recent Mergers and Acquisitions
- Revenue of Test Service Companies
- Geographic Breakout of Molecular Diagnostics Market by Region (North America, Europe, Asia, ROW)
- Sample Prep Market, 2010 and 2015
- Breakout of Molecular Histology/Cytology Market (in situ hybridization, HPV, Tissue Microarrays), 2010 and 2015
- Important CLIA Lab Developments, 2008-2010
More and more laboratories offer complex panels of tests that help physicians evaluate disease risk and make therapeutic decisions. Government and private healthcare payors have recognized the value of new molecular tools and have agreed to pay for them.
This renewed interest in IVDs in general and more particularly in molecular diagnostics has lead to the commercialization of a number of technological tools that make more sensitive and specific tests possible. Some of these technological innovations include: cost-effective, multiplexed testing platforms coupled with high-powered software capabilities. In addition analyses using saliva, urine, and blood instead of biopsied tissue make for more patient-friendly test systems.
Contents
- Chapter One: Executive Summary
- Introduction
- Scope and Methodology
- Size and Growth of The Market
- Market Trends
- Chapter Two: Introduction
- Background - Developments since 2000
- New Platforms
- Quality Control Products
- Building A Strong Future - Hot, Hot, Hot
- The Sequence Begins
- Personalizing Risk and Therapies
- Ldts Reign
- The $1000 Genome - If and When
- Luke Warm Trends
- Miniaturization and Multiplexed Assays
- Integrated Sample Preparation and System Automation
- Mass Spectroscopy
- Screening for Wellness
- Chapter Three: The Commercialization Conundrum
- Background
- Reimbursement of Novel Tests
- Regulatory Issues and Molecular Assays
- Commercializing Molecular Diagnostics -
- Physician Acceptance
- U.S. Health Care Reform and Molecular Testing
- Chapter Four: Market Analysis
- Background
- Worldwide Opportunities for Molecular Tests
- The United States
- Europe
- Japan
- China
- India
- Molecular Diagnostics and Target Markets
- The Market for Molecular Assays in Cancer Management
- Liquid Biopsies - Ctcs
- Tumor Markers
- Sequencing
- Chromosome Analysis
- The Market for Molecular Assays in Hematology
- The Market for Molecular Assays in Coagulation
- The Market for Molecular Assays in Histopathology/Cytology
- Overview
- The Pap Smear & Hpv Testing
- Fish Goes Digital, Multiplexed and Quantitative
- Tissue Microarrays
- Pharmacodiagnostic Test Applications
- Chapter Five: Conclusions and Strategic Implications - 2015 and beyond
- Conclusion One
- Implication
- Conclusion Two
- Implication
- Conclusion Three
- Implication
- Conclusion Four
- Implication
- Conclusion Five
- Implication
- Conclusion Six
- Implication
- Conclusion Seven
- Implication
- Conclusion Eight
- Implication
- Chapter Six: Major Companies and Vendors to Watch
- Background
- Acquisitions, Alliances and Collaborations in Molecular Diagnostics
- Company Triage
- The Majors
- Abbott Diagnostics
- Recent Revenue History )
- Key Comment
- Molecular Histology
- Molecular Diagnostics
- Microbiology
- Molecular Sample Prep
- Alere (Formerly Inverness Medical Innovations)
- Recent Revenue History
- Key Comment
- Becton, Dickinson and Company (Bd)
- Recent Revenue History
- Key Comment
- Histology
- Microbiology
- Expanding Molecular Testing Capabilities.
- Beckman Coulter Inc.
- Recent Revenue History
- Key Comment
- Research Markets
- Biomérieux Inc.
- Marcy L'etoile, France Www.Biomérieux.Fr Recent Revenue History
- Key Comment
- Molecular
- Gen-Probe Inc.
- Recent Revenue History
- Key Comment
- Gti Acquisition
- Transplant/Hla Testing
- Infectious Diseases
- Blood Bank
- Oncology
- Hologic, Inc.
- Recent Revenue History
- Key Comment
- Histology
- Instrumentation Laboratory (Il)
- Recent Revenue History
- Key Comment
- Qiagen N.V.
- Recent Revenue History
- Key Comment
- Histology
- Infectious Diseases
- Oncology
- Roche Diagnostics
- Recent Revneue History
- Key Comment
- Histology
- H1n1/ Applied Sciences
- Pcr
- Infectious Diseases
- Blood Bank
- Personalized Medicine - Companion Tests
- Research
- Siemens Healthcare Diagnostics
- Recent Revenue
- Key Comment
- Sysmex Corporation
- Recent Revenue History:
- Key Comment
- Thermo Fisher Scientific Inc.
- Recent Revenue History
- Key Comment
- The Participants
- Affymetrix, Inc.
- Recent Revenue History
- Key Comment
- Agendia Bv
- Recent Revenue History
- Key Comment
- Agilent Technologies Inc.
- Recent Revenue History
- Key Comment
- Asuragen, Inc.
- Recent Revenue History
- Key Comment
- Aviaradx (Biomerieux)
- Ambry Genetics
- Recent Revenue History
- Key Comment
- Bio-Reference Laboratories, Inc. (Brli)
- Recent Revenue History
- Key Comment
- Caliper Life Sciences, Inc.
- Recent Revenue History
- Key Comment
- China Medical Technologies, Inc.
- Recent Revenue History
- Key Comment
- Clarient Inc. (Formerly Chromavision)
- Recent Revenue History
- Key Comment
- Decode Genetics Ehf
- Recent Revenue History
- Key Comment
- and Others...
- The Stars
- Advandx, Inc.
- Recent Revenue History
- Key Comment
- Celera Diagnostics
- Recent Revenue History
- Key Comment
- Berkeley Heartlab (Bhl)
- Product Development
- Cepheid
- Key Comment
- Instrumentation
- Dxs Ltd.
- Recent Revenue History
- Key Comment
- and Others...
- Newcomers
- Akonni Biosystems Inc.
- Applied Biocode, Inc.
- Arrayit Diagnostics Inc.
- Exiqon A/S
- and Others...
- High Potential Companies
- Adnagen Ag
- Allegro Diagnostics
- and Others...
- Histology Specialists
- Advanced Cell Diagnostics
- Perceptronix Medical Inc. (Pmi Labs)
- Microbiology Specialists
- Adnavance Technologies Inc.
- Capitalbio Corporation
- Cooperative Diagnostics, Llc
- and Others...
- Quality Control Specialists
- Acrometrix
- Bio-Rad Laboratories Inc.
- Paragondx Llc (Formerly Gentris Diagnostics Inc.)
- Sample Prep Specialists
- Arcxis Biotechnologies
- Argylla Technologies Llc
- Biomatrica, Inc.
- and Others...